Compartilhar
Informação da revista
Vol. 45. Núm. 3.
Páginas 412-413 (julho - setembro 2023)
Vol. 45. Núm. 3.
Páginas 412-413 (julho - setembro 2023)
Images in Clinical Hematology
Acesso de texto completo
Strongyloides stercoralis: Intriguing cough in an acute lymphoblastic leukemia patient
Visitas
2659
Michael Blaine Wintertona, Ghulam Ghousb,
Autor para correspondência
ggkm5@health.missouri.edu

Corresponding author at: 1 Hospital Dr, Columbia, MO 65212, Columbia, MO, USA.
a PGY3 Internal Medicine Resident, University of Missouri, Columbia, MO, USA
b Ellis Fischel Cancer Center, University of Missouri, Columbia, MO, USA
Este item recebeu
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (1)
Texto Completo

A 32-year-old Guatemalan female presented to our Institution with dyspnea, dull chest pain, nonproductive cough, and diffuse pruritic rash. She reported that her symptoms had aggravated over the previous week. She has Acute Lymphoblastic Leukemia treated with cyclophosphamide, vincristine, doxorubicin, and dexamethasone that was last administered three weeks prior to presentation.

Upon arrival, she had tachycardia at 112 beats per minute, WBC 20,680/L, Hemoglobin 9.0 g/dL, ALT 56 units/L, Lactate Dehydrogenase 358 units/L. Imaging revealed no acute infectious findings. Despite starting broadspectrum antibiotics and steroids, her dyspnea progressed and she required oxygen support. Repeat labs revealed WBC 21,570/L with eosinophils of 1730/L. Bronchoscopy was conducted and bronchoalveolar lavage revealed Strongyloides (Figure 1).

Figure 1.

Bronchoalveolar lavage fluid showing Strongyloides stercoralis.

(0.48MB).

Pathology confirmed Strongyloides stercoralis. Antibiotics and steroids were discontinued. Ivermectin 200 mcg/kg was initiated.1 Repeat BAL after two weeks of Ivermectin revealed no signs of infection. Chemotherapy was resumed after four weeks of Ivermectin. Interestingly, her stool for ova and parasite and IgG for Strongyloides stercoralis were negative.

Parasitic infections including Strongyloides stercoralis should be considered in immunocompromised patients with eosinophilia that don't improve with broad-spectrum antibiotics.

Reference
[1]
V Luvira, D Watthanakulpanich, P. Pittisuttithum.
Management of Strongyloides stercoralis: a puzzling parasite.
Int Health, 6 (2014), pp. 273-281
Copyright © 2022. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Baixar PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas